Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Dimopoulos

Showing results (321-330 of 383) with videos related to

Pageof 39
Sort By:
Intensive Care Medicine|March 4, 2017
Intensive care medicine research agenda on invasive fungal infection in critically ill patientsMatteo Bassetti, Jose Garnacho-Montero, Thierry Calandra, et al.
Microorganisms|November 8, 2019
Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary MucormycosisChun-Yu Lin, I-Ting Wang, Che-Chia Chang, et al.
Critical Care (London, England)|March 10, 2016
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT studyJosé-Artur Paiva, José Manuel Pereira, Alexis Tabah, et al.
Chest|November 29, 2016
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS TrialMarin H Kollef, Jean-Damien Ricard, Damien Roux, et al.
Critical Care (London, England)|June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI studyStijn Blot, Despoina Koulenti, Murat Akova, et al.
Critical Care (London, England)|April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients StudyMahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Infectious Diseases and Therapy|May 14, 2020
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study GroupDimitrios Velissaris, George Dimopoulos, John Parissis, et al.
Intensive Care Medicine|March 27, 2019
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patientsIgnacio Martin-Loeches, Massimo Antonelli, Manuel Cuenca-Estrella, et al.
Anaesthesia, Critical Care & Pain Medicine|November 11, 2020
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposiumJordi Rello, Mirko Belliato, Meletios-Athanasios Dimopoulos, et al.
Pageof 39

Showing results (321-330 of 383) with videos related to

Sort By:
Pageof 39
Intensive Care Medicine|March 4, 2017
Intensive care medicine research agenda on invasive fungal infection in critically ill patientsMatteo Bassetti, Jose Garnacho-Montero, Thierry Calandra, et al.
Microorganisms|November 8, 2019
Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary MucormycosisChun-Yu Lin, I-Ting Wang, Che-Chia Chang, et al.
Critical Care (London, England)|March 10, 2016
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT studyJosé-Artur Paiva, José Manuel Pereira, Alexis Tabah, et al.
Chest|November 29, 2016
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS TrialMarin H Kollef, Jean-Damien Ricard, Damien Roux, et al.
Critical Care (London, England)|June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI studyStijn Blot, Despoina Koulenti, Murat Akova, et al.
Critical Care (London, England)|April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients StudyMahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Infectious Diseases and Therapy|May 14, 2020
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study GroupDimitrios Velissaris, George Dimopoulos, John Parissis, et al.
Intensive Care Medicine|March 27, 2019
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patientsIgnacio Martin-Loeches, Massimo Antonelli, Manuel Cuenca-Estrella, et al.
Anaesthesia, Critical Care & Pain Medicine|November 11, 2020
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposiumJordi Rello, Mirko Belliato, Meletios-Athanasios Dimopoulos, et al.
Pageof 39